Trial of Chinese Prescription on Ulcerative Colitis
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2009
CompletedStudy Start
First participant enrolled
August 1, 2009
CompletedFirst Posted
Study publicly available on registry
August 21, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedApril 19, 2016
August 1, 2009
1.9 years
June 11, 2009
April 18, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Histopathological examination,enteroscopy,blood test,symptoms ,pulse tracings,tongue demonstration
8 weeks
Secondary Outcomes (1)
Indicates of liver and renal function
8 weeks
Study Arms (2)
bascial prescription
EXPERIMENTALDecoction ,two times a day,one bag of decoction one time
low does of bascial decoction
PLACEBO COMPARATORDecoction ,two times a day, one bag decoction of one time
Interventions
Decoction ,two times a day
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of ulcerative colitis
- Male of female patients between 18-65 years old
- Written informed consent
You may not qualify if:
- Combine with malignant pathology on epithelial dysplasia of mucosa
- Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
- Pregnancy or breast feeding women, or unwilling to have contraception.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Longhua hospital
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Xie Jianqun, Phd
Shanghai University of Chinese Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2009
First Posted
August 21, 2009
Study Start
August 1, 2009
Primary Completion
July 1, 2011
Study Completion
August 1, 2011
Last Updated
April 19, 2016
Record last verified: 2009-08